Dianthus Therapeutics, Inc. (DNTH) Misses Q3 EPS by 349c

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) reported Q3 EPS of ($3.78), $3.49 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Dianthus Therapeutics, Inc. (DNTH) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• Morgan Stanley Resumes Victoria Secret (VSXY) at Overweight